XFPC may regulate autophagy by down-regulating the expression of CSF1, MAPK9, MAP3K7, and AKT3, thus achieving the purpose of treating chronic obstructive pulmonary disease. This evidence concerns the gene AKT3 and chronic obstructive pulmonary disease.